Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies
December 20, 2021 07:05 ET
|
Senti Bio
- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common...
Senti Bio CEO Appointed to The Alliance for Regenerative Medicine 2022 Board of Directors
October 21, 2021 09:05 ET
|
Senti Bio
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced that its co-founder and chief executive officer, Tim Lu, MD, PhD, has been...
Senti Bio Signs Lease Agreement and Begins Design of Clinical and Commercial-Scale Manufacturing Facility for Allogeneic CAR-NK Cell Therapies
June 15, 2021 16:00 ET
|
Senti Bio
- 92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline - - Facility to initially focus on preclinical product...
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ISCT Annual Meeting
May 25, 2021 08:00 ET
|
Senti Bio
- Senti Bio has designed a scalable process for efficient manufacturing of allogeneic CAR-NK cell pipeline - - Large scale expansion of PBMC-NK cells and UCB-NK cells may provide a scalable source...
Senti Bio Announces Key Leadership Appointments
May 19, 2021 08:00 ET
|
Senti Bio
- Deborah Knobelman, PhD, appointed Chief Financial Officer - - Curt Herberts, MBS, promoted to Chief Operating Officer and Philip Lee, PhD, promoted to Chief Technology Officer - SOUTH SAN...
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ASGCT 24th Annual Meeting
May 11, 2021 08:00 ET
|
Senti Bio
- Using Logic Gating gene circuits, Senti Bio is engineering allogeneic CAR-NK cells to target and more precisely eliminate cancer cells while sparing healthy cells - - Using a Regulator Dial...
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at Upcoming Scientific Conferences
April 21, 2021 16:00 ET
|
Senti Bio
SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Senti Bio, a leading gene circuit company, today announced the acceptance of five abstracts for presentation at upcoming virtual...